Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021.
Euro Surveill
; 27(46)2022 11.
Article
in English
| MEDLINE | ID: covidwho-2115722
ABSTRACT
Recent data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show a large increase of +57% in Acinetobacter species bloodstream infections in the European Union and European Economic Area in the first years of the COVID-19 pandemic (2020-2021) compared with 2018-2019. Most were resistant to carbapenems, from intensive care units, and in countries with ≥ 50% carbapenem resistance in Acinetobacter spp. in 2018-2019. This highlights the requirement for reinforced Acinetobacter preparedness and infection prevention and control in Europe.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Acinetobacter
/
Sepsis
/
COVID-19
Limits:
Humans
Language:
English
Journal subject:
Communicable Diseases
Year:
2022
Document Type:
Article
Affiliation country:
1560-7917.es.2022.27.46.2200845
Similar
MEDLINE
...
LILACS
LIS